BTL Biotechno Labs Pvt. Ltd.: Authorized Distributor of Matriks Biotek Therapeutic Drug Monitoring and Immunogenicity Assays in India

Precision medicine is transforming the management of chronic diseases, autoimmune disorders, oncology, and inflammatory conditions. As biologic therapies become increasingly important, monitoring drug concentrations and immunogenicity has become essential for optimizing treatment outcomes. Supporting this advancement is Matriks Biotek, a globally recognized biotechnology company specializing in Biological Drug Monitoring (BDM) and innovative ELISA technologies.

Founded in 2002 in Türkiye by Prof. Haluk Ataoglu, MD, PhD, Matriks Biotek has established itself as a pioneer in medical biotechnology. The Matriks Biotek became the world's first organization to develop and commercialize Biological Drug Monitoring ELISA kits under the SHIKARI® brand, setting new standards for therapeutic drug monitoring worldwide.

BTL Biotechno Labs Pvt. Ltd. – Authorized Distributor of Matriks Biotek in India

BTL Biotechno Labs Pvt. Ltd. is committed to delivering premium life science research and diagnostic solutions by providing authentic products, expert technical consultation, prompt customer support, and reliable nationwide supply.

As an authorised distributor of Matriks Biotek, BTL Biotechno Labs  offers:

•  Matriks Biotek products
• Expert technical guidance
• Fast and reliable delivery across India
• Product selection assistance
• Prompt quotation support
• After-sales technical support
• Dedicated customer service for research and diagnostic laboratories

Comprehensive Product Portfolio

Matriks Biotek offers specialized ELISA-based solutions designed for therapeutic drug monitoring, immunogenicity testing, and infectious disease research.

SHIKARI® Biological Drug Monitoring ELISA Kits

SHIKARI® ELISA Kits are globally recognized for quantitative monitoring of biological therapies. These kits are widely used for measuring drug concentrations and anti-drug antibodies (ADA), supporting personalized treatment decisions.

Applications include monitoring biologics used in:

• Gastroenterology
• Rheumatology
• Dermatology
• Oncology
• Autoimmune diseases
• Inflammatory bowel disease (IBD)

The product portfolio covers numerous biologic drugs, including anti-TNF therapies, monoclonal antibodies, checkpoint inhibitors, and other targeted biologics.

Anti-Drug Antibody (ADA) ELISA Kits

Immunogenicity can reduce the effectiveness of biologic therapies. Matriks Biotek provides highly sensitive ELISA kits for detecting anti-drug antibodies, enabling clinicians to identify loss of response and make informed treatment adjustments.

Therapeutic Drug Monitoring (TDM) Kits

Therapeutic Drug Monitoring allows to:

• Measure trough drug levels
• Optimize dosing schedules
• Improve therapeutic efficacy
• Reduce unnecessary dose escalation
• Lower healthcare costs
• Support personalized medicine

These quantitative assays provide reliable information for effective biologic therapy management.

CoronaHunter® ELISA Kits

Matriks Biotek also developed the innovative CoronaHunter® product range, offering quantitative ELISA kits for measuring antibodies against multiple SARS-CoV-2 antigens.

Features include:

• Quantitative IgG assays
• IgA detection
• IgM detection
• IgE detection
• Multiple viral antigen targets including Spike S1, RBD, Trimer, and Nucleocapsid proteins

These kits are designed for research applications requiring precise antibody quantification.

High Analytical Performance

SHIKARI® ELISA Kits are designed to deliver:

• High sensitivity
• Excellent specificity
• Low inter-assay variation
• Low intra-assay variation
• Reliable reproducibility
• Ready-to-use stabilized reagents

These characteristics ensure dependable performance in research and clinical laboratories.

Supporting Personalized Medicine

Rather than relying solely on clinical symptoms, biological drug monitoring enables treatment decisions based on objective laboratory measurements, improving therapeutic outcomes while minimizing adverse effects.

As precision medicine continues to shape modern healthcare, reliable biological drug monitoring has become increasingly important for optimizing biologic therapies and improving patient outcomes. Matriks Biotek has emerged as a global leader in therapeutic drug monitoring, anti-drug antibody detection, and quantitative ELISA technologies through its innovative SHIKARI® and CoronaHunter® product lines.

Through BTL Biotechno Labs Pvt. Ltd., the authorized distributor of Matriks Biotek products in India, researchers, hospitals, pharmaceutical companies, and diagnostic laboratories can access these world-class technologies with trusted local support, scientific expertise, and dependable product availability.

For product details, please connect with us at info@biotechnolabs.com.